Palvella Therapeutics raises $3M to advance rare disease drug
April 15, 2019 at 06:40 AM EDT
The money will help the Wayne company continue development of its therapy for pachyonychia congenita.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.